{"lastClose": 1.190000057220459, "len": 485, "date": "2023-02-21", "alpha_1": -0.9020465982780627, "beta_1": 0.17320569626549528, "drawup_1": 0.7325581218050006, "natr_1": 30.74029487973598, "sup_1": -0.061344596573744865, "res_1": 0.22941165510169653, "bullPattern_1": ["BELTHOLD", "CLOSINGMARUBOZU", "LONGLINE", "MARUBOZU"], "bearPattern_1": [], "rsi_1": 63.86138371376134, "adx_1": 46.47012610215787, "drawdown_1": -0.9048152301462742, "stratHoldSharpe_1": -1.6368963605594793, "stratHoldAlpha_1": 249.83840471305803, "stratHoldDrawdown_1": -0.8274920353872628, "alpha_3mo": -0.3626606599877821, "beta_3mo": -0.25080056959421343, "drawup_3mo": 0.4117647223819081, "natr_3mo": 30.74029487973598, "sup_3mo": -0.04761906670016541, "res_3mo": 0.1736694607719981, "bullPattern_3mo": [], "bearPattern_3mo": ["HANGINGMAN"], "rsi_3mo": 72.47705960472625, "adx_3mo": 37.558068145114966, "drawdown_3mo": -0.4295301889923263, "stratHoldSharpe_3mo": -1.1697917075818993, "stratHoldAlpha_3mo": 250.31445379206292, "stratHoldDrawdown_3mo": -0.38657717009309367, "Market Cap": 295658587, "Industry": "Biotechnology: In Vitro & In Vivo Diagnostic Substances", "Country": "Cayman Islands", "Name": "LumiraDx Limited", "Sector": "Health Care", "alpha%_1": 0.003777362637737692, "beta%_1": 0.05592479603153264, "drawup%_1": 0.6864925609817198, "natr%_1": 1.0, "drawdown%_1": 0.0034794419776718265, "stratHoldSharpe%_1": 0.007673693141383675, "stratHoldAlpha%_1": 1.4197920731893962e-06, "stratHoldDrawdown%_1": 0.003547202763370807, "alpha%_3mo": 0.1504661553726941, "beta%_3mo": 0.016985402177686085, "drawup%_3mo": 0.8240285368894015, "natr%_3mo": 1.0, "drawdown%_3mo": 0.0003050297612249109, "stratHoldSharpe%_3mo": 0.13170712631687298, "stratHoldAlpha%_3mo": 0.04827274771490349, "stratHoldDrawdown%_3mo": 0.0003771175898979966}